Heart rate as a possible therapeutic guide for the prevention of cardiovascular disease.

Item

http://www.wikidata.org/entity/Q38130624

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Heart rate as a possible therapeutic guide for the prevention of cardiovascular disease.

@en

type

Item

label

Heart rate as a possible therapeutic guide for the prevention of cardiovascular disease.

@en

prefLabel

Heart rate as a possible therapeutic guide for the prevention of cardiovascular disease.

@en

P1476

Heart rate as a possible therapeutic guide for the prevention of cardiovascular disease

@en

P2093

Kunitoshi Iseki

http://www.w3.org/2001/XMLSchema#string

Yusuke Ohya

http://www.w3.org/2001/XMLSchema#string

P2860

TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation : An Intravenous nPA for Treatment of Infarcting Myocardium Early II Trial Substudy

Heart rate and use of beta-blockers in stable outpatients with coronary artery disease

Association of heart rate with microalbuminuria in cardiovascular risk patients: data from I-SEARCH.

Usefulness of heart rate at rest as a predictor of mortality, hospitalization for heart failure, myocardial infarction, and stroke in patients with stable coronary heart disease (Data from the Treating to New Targets [TNT] trial).

Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST).

Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans.

Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review.

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.

Funny channels in the control of cardiac rhythm and mode of action of selective blockers.

Optimal medical therapy with or without PCI for stable coronary disease.

P2888

hr.2013.98

P304

838-844

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/HR.2013.98

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Taku Inoue

P577

2013-08-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256076334

http://www.w3.org/2001/XMLSchema#string

P698

23966053

http://www.w3.org/2001/XMLSchema#string